Canadian Regulations Safety of Human Cells, Tissues and Organs (CTO) for Transplantation
|
|
- Kerry Alexander
- 8 years ago
- Views:
Transcription
1 Canadian Regulations Safety of Human Cells, Tissues and Organs (CTO) for Transplantation Presentation to the American Association of Tissue Banks Savannah, Georgia March 2008
2 Health Canada Update Marianne Tang Manager CTO Regulatory Policy Unit Biologics and Genetic Therapies Directorate Health Products and Food Branch Health Canada (613)
3 Overview Health Canada s mandate and authority New CTO regulatory framework Implementing the new regulations Establishment Registration Process Adverse Reaction & Error/Accident Reporting Transitional Provisions Health Canada Guidance Document for Establishments Keep the CSA Standard current ( Standard-based regulations ) Evaluation of effectiveness of the regulations 3
4 Health Canada Principles Safety and prevention of disease transmission is key Nationally integrated approach required Transparent Clear accountability Harmonize internationally when possible, but identify areas where we can lead 4
5 Mandate To take an integrated approach to the management of risks and benefits to health related to health products and food by minimizing risk factors to Canadians while maximizing safety provided by the regulatory system authority provided under the Food and Drugs Act and Regulations emphasis on product safety and informed use 5
6 Regulating Cells, Tissues and Organs Key Considerations Federal/ Provincial/ Territorial Responsibility 10 provinces and 3 territories, each with responsibility over of management and delivery of healthcare within International Share border with US, with exchange of CTO across border in each direction 6
7 Regulating CTO Key Considerations Donor Family P/T Governments (Delivery) Liver Transplant Program Heart Transplant Program Kidney Transplant Program Patient Patient Patients Organ and Tissue Donor Donor Establishment of Origin Organ Donation Organization Lung Transplant Program Patient(s) The Need for Traceability Health Canada (Product Safety) Eye Bank Tissue Bank (Bone) Islet Cell Transplant Program Cornea Tx Programs Ortho Programs (multiple) Patient Patients Patients Tissue Bank (Heart Valves) Cardiovascular Programs Patients 7
8 New CTO Regulations Published in June 2007 and came into force on December 7, 2007, following extensive consultation over a period of 11 years with the transplant community and Canadians. Companion Guidance Document also published Regulate the safety, efficacy, and quality of CTOs as therapeutic products under the Food and Drugs Act. we therefore regulate the product, but not the practice Purpose is to minimize the potential health risks to Canadian recipients resulting from transplantation. 8
9 New CTO Regulations Reflects best practices ongoing in Canada in the field of transplantation since the mid 1990 s and enshrine these requirements into law so that transplantation will remain safe to Canadian patients. Safety regulations incorporate by reference national standards that have been developed by the Canadian Standards Association (CSA), with additional requirements for compliance monitoring and adverse reaction, error and accident reporting strategies 9
10 CTO Regulatory Framework Why Standard-Based Regulations? Balanced representation of stakeholders in development process Consensus approach may enhance future compliance Written in non-legal/regulatory language Easier to update than regulations 10
11 CSA National Standards In 2001, Health Canada funded the Canadian Standards Association (CSA) to develop the standards Published in 2003 and updated Nov 2004 Content developed by group of experts in various transplant domains: One general standard and five subset standards Cells, Tissues and Organs for Transplantation and Assisted Reproduction: General Requirements (CAN/CSA Z900.1) Tissues for Transplantation (CAN/CSA Z ) Others for organs, ocular, lymphohematopoietic, assisted reproduction 11
12 CTO Regulatory Framework Developing Standards-Based Regulations Standards are made mandatory only when: incorporated directly into regulations, or referenced in regulations Health Canada can only use sections of the standards that are: under federal authority; absolute requirements 12
13 CTO Regulations Scope Applies to organs and minimally manipulated cells and tissues Structural tissue: the processing does not alter the original characteristics that are relevant to its claimed utility for reconstruction, repair or replacement Cells and nonstructural tissue: the processing does not alter the biological characteristics that are relevant to their claimed utility Intended for allogeneic use Intended for homologous use 13
14 CTO Regulatory Framework Scope Cells and Tissues meeting any of the following criteria will be regulated under the drug or medical device regulations: more than minimally manipulated; intended for non-homologous use; have a systemic effect and depend on their metabolic activity for their primary function (except islet cells and lymphohematopoietic cells from bone marrow, peripheral blood and cord blood); subject of investigational studies or clinical trials in humans combined with non-tissue products, including drugs and devices 14
15 CTO Regulatory Framework Provisions Registration All Source Establishments (including US based) or establishments that import CTO have to register Canadian Establishments may only import CTO from establishments that have registered with Health Canada Source Establishment The term source establishment refers to the source of the CTO that has undergone all processing and is now safe for transplantation It is responsible for the processing of CTO, whether it is carried out on its behalf or accomplished by itself It is also responsible for determining whether CTO are safe for transplantation Processing This activity includes the screening, testing and suitability assessment of donors (as set out in the CSA standard), as well as the testing and measurements performed on the CTO after retrieval (e.g., microbiological tests) retrieval, preparation and preservation, packaging and labelling, quarantine, and banking of CTO 15
16 Implementing the new CTO Regulations 16
17 Establishment Registration Establishments that must register Every Source Establishment - foreign or domestic Establishments that import and distribute Exemption import directly to transplant only e.g. dentists 17
18 Establishment Registration Contents of application for registration Establishment contact information Description of CTO and activities Attestation to compliance with CTO Regulations Upon request, any relevant information required to complete the application or demonstrate compliance with the Regulations 18
19 Establishment Registration Since the June 2007 publication date of the CTO Regulations, establishments have been completing and sending their registration applications to Health Canada List of all registered establishments will be available on the Health Canada website soon 19
20 Establishment Registration Registration numbers are issued if information is complete May be refused if information is false, misleading, inaccurate or incomplete May be suspended or revoked due to serious adverse reactions or failure to comply with the Regulations All CTO Registration numbers expire on December 31 st of the year following the year in which it was issued 20
21 Establishment Registration Notification required Within 30 days of any change in information provided in the application Within 90 days of ceasing an activity and provided information on the disposition of cells/tissues in establishment s possession 21
22 Error/Accident (E/A) and Adverse Reaction (AR) Reporting and Investigation Establishments that have reason to believe an E/A or unexpected AR has occurred must: Determine nature of E/A or AR and identify implicated CTO Notify the source establishment and other establishments from which they received CTO or to which they distributed CTO All establishments must immediately quarantine any implicated CTO in their possession until the source establishment completes an investigation 22
23 E/A, AR Reporting and Investigation Source Establishment must: initiate an investigation without delay notify Health Canada in writing of the investigation if the E/A could lead to serious AR involving an infectious disease, or if an unexpected serious AR potentially involves an infectious disease provide Health Canada with a report within 24 hours, provide updates on steps taken every 30 days and provide a final report upon completion of the investigation, including results of the investigation, final disposition of CTO and corrective actions taken notify other establishments in writing of the results of the investigation Other establishments must provide the source establishment with any relevant information required to conduct the investigation 23
24 Adverse Reaction Reporting Guidance Document for Source Establishments reporting Adverse Reactions to Human Cells, Tissues and Organs Will provide information and instructions for filling out MedEffect Canada forms for reporting Adverse Reactions Canada Vigilance HC/SC 4016 form 24
25 Transitional Provisions Cells and tissues that were processed within five years before the regulations are registered can only be imported and/or distributed by a registered establishment CTO processed prior to the coming into force of the CTO Regulations must meet certain safety requirements, namely that every registered and transplant establishment must ensure that the donor identification code is a component of its record system, and that all establishment records must contain information with respect to all CTO that it processes, distributes, imports or transplants that identifies both the establishment from which it received the CTO, and all establishments to which it will be distributed These provisions will remain in effect for five years 25
26 Finalize Guidance Document Guidance Document for Cell, Tissue and Organ Establishments Cells, Tissues and Organs for Transplantation Comments from initial draft posted on Health Canada website June 2007 are being considered and final document will be posted on the Health Canada website this summer 26
27 Compliance verification of Foreign Source Establishments Foreign source establishments must register with Health Canada certify compliance with the CTO Regulations the CTO product has been declared safe for transplantation Through a Memorandum of Understanding with the US FDA Health Canada is able to obtain information for its inspection and investigation activities If Health Canada has reasons to believe that the safety of cells, tissues or organs has been or could be compromised it has the ability to cancel a foreign establishment's registration number, thereby preventing Canadian importers from importing and using tissue processed by the establishment 27
28 Evaluate regulations Evaluation will be conducted in early 2009 Are the CTO regulations effective? What can be improved? Some areas to evaluate: - Is the standards based approach working to allow faster updating of the regulations as technological changes? - Are risk management & inspection strategies geared to maximize safety while balancing availability and quality of the CTO? - In emergencies are lookback/traceback systems working to identify the source of the risk? 28
29 Important Points to Take Home CTO Regulations came into force on December 7, 2007 Health Canada s authority is over Product Safety and not transplantation Canadian establishments may only import CTO that is processed and determined safe for transplant by an establishment registered with Health Canada The registration application includes a signed statement that the establishment is compliant with the Regulations The Source Establishment is responsible for the processing and for determining whether the CTO are safe for transplantation 29
30 CTO Regulatory Framework Summary & Conclusion In general, the Regulations contain broad goals that are applicable to a wide range of CTO (i.e., specifies what but not how) Establishments have the flexibility to determine how to meet these goals by developing specific requirements for the CTO they process The ultimate goal of the regulatory framework is to balance the need for safe CTO with the need to ensure availability of CTO for transplantation. 30
US Regulations for Import and Export of Cell Therapy Products
US Regulations for Import and Export of Cell Therapy Products Kurt Gunter, MD U Minnesota UCB Transplants (2001-2007)* Total units: 790 Number US banks: 19 Number non-us banks: 12 % units from non-us banks:
More informationHealth Products and Food Branch. www.hc-sc.gc.ca
Health Products and Food Branch 1 HEALTH CANADA PART C DIVISION 5 - DRUGS FOR CLINICAL TRIALS INVOLVING HUMAN SUBJECTS Part C - Division 5 2 Part A: Part B: Part C: Part D: Part E: Part G: Part J: Administration
More informationPublic Cord Blood Bank
The The Public Cord Blood Bank Page 1 of 21 TABLE OF CONTENTS INTRODUCTION... 3 WHAT ARE GOOD MANUFACTURING PRACTICES?... 5 1 TOTAL QUALITY... 7 2 PREMISES... 8 3 EQUIPMENT AND MATERIAL... 9 4 PERSONNEL...
More information[DOCKET NO.96N-0002] DRAFT
[DOCKET NO.96N-0002] DRAFT DRAFT DOCUMENT CONCERNING THE REGULATION OF PLACENTAL/UMBILICAL CORD BLOOD STEM CELL PRODUCTS INTENDED FOR TRANSPLANTATION OR FURTHER MANUFACTURE INTO INJECTABLE PRODUCTS DECEMBER,
More informationGuide to Regulatory Requirements for the Procurement of Human Tissues and Cells intended for Human Application
Guide to Regulatory Requirements for the Procurement of Human Tissues and Cells intended for Human AUT-G0102-1 3 JANUARY 2013 This guide does not purport to be an interpretation of law and/or regulations
More informationClinical Trials and Safety Surveillance of Drugs in Development
Clinical Trials and Safety Surveillance of Drugs in Development Hoda Eid, M.Sc., Ph.D. Manager, ADR Unit Office of Clinical Trials Therapeutic Products Directorate hoda_eid@hc-sc.gc.ca Overview Clinical
More informationHealth Canada s GCP Compliance Program. GCP Information Sessions November 2010
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité Health Canada s GCP Compliance Program GCP Information Sessions November 2010 Objective To describe the role that Health
More information"Act" means the National Health Act, 2003 (Act No 61of 2003);
142 No.35099 GOVERNMENT GAZETTE, 2 MARCH 2012 No. R. 183 2 March 2012 NATIONAL HEALTH ACT, 2003 REGULATIONS'RELATING TO STEM CELL BANKS The Minister of Health has, in terms of section 68 of the Health
More informationHow To Inspect A Blood Bank
Site visit inspection report on compliance with HTA minimum standards Belfast Cord Blood Bank HTA licensing number 11077 Licensed for the procurement, processing, testing, storage, distribution and import/export
More informationA Real Time Lab for Pan Canadian Innovation Leveraging Canadian Blood Services Model for Better Value to Health care Systems
A Real Time Lab for Pan Canadian Innovation Leveraging Canadian Blood Services Model for Better Value to Health care Systems November 14, 2014 Submission to the Advisory Panel on Health Care Innovation
More informationOneMatch National. Sue Smith, Executive Director, Stem Cells 2011-11- 04
OneMatch National Public Cord Blood Bank Blood Matters 2011 Sue Smith, Executive Director, Stem Cells 2011-11- 04 No Disclosures To Declare The presenter does not have any involvement with the industry
More informationAct for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations
Act for Appropriate Provision of Hematopoietic Stem Cells to be Used in Transplantations Contents Chapter 1 General Provisions (Article 1 Article 8) Chapter 2 Basic Policy (Article 9) Chapter 3 Measures
More informationUniversity of Colorado Hospital Policy and Procedure Transplant and Implant Tissue Storage and Issuance
University of Colorado Hospital Policy and Procedure Transplant and Implant Tissue Storage and Issuance Related Policies and Procedures: Temperature Controlled Storage Unit Monitoring Hospital Infection
More informationIt s not something you want to think about, but it s something you want to prepare for.
It s not something you want to think about, but it s something you want to prepare for. StemCyte cord blood banking offers your family a new lifesaving treatment alternative Why Bank Take the once-in-alifetime
More informationStem Cell Background Paper
Stem Cell Background Paper Introduction...2 Stem Cell Basics...3 Stem Cell Process Flow...9 Comparison of Blood, Stem Cells, Tissues and Organs Processes...10 Responsibilities for the Blood, Stem Cells,
More informationWORLD HEALTH ORGANIZATION
WORLD HEALTH ORGANIZATION First Global Consultation on Regulatory Requirements for Human Cells and Tissues for Transplantation Ottawa, 29 November to 1 December 2004 Report WHO Library Cataloguing-in-Publication
More informationCLIENT AGREEMENT. Copyright 2014 MiracleCord Inc. All rights reserved.
CLIENT AGREEMENT MiracleCord, Inc. is a provider of services for the collecting, testing, processing, cryopreserving and storing of cells collected from a newbornʼs umbilical cord blood ( Cord Blood )
More informationAMERICAN INTERNATIONAL COMPANIES Page 1 ORGAN PROCUREMENT ORGANIZATION & TISSUE BANK SUPPLEMENTAL APPLICATION
AMERICAN INTERNATIONAL COMPANIES Page 1 This is a Supplemental Application which becomes part of the Lexington Miscellaneous Facilities Application. The Applicant represents that the statements and facts
More informationHow To Know If You Can Get A Blood Test For Hct/P
FDA/CBER Compliance Update EBAA Leadership and Advocacy Meeting February 13, 2014 Mary Malarkey, Director Office of Compliance and Biologics Quality Summary Registration Inspections Regulatory Actions
More informationHematopoietic stem and progenitor cell transplants: regulation and accreditation
Pediatr Transplantation 2003: 7 (Suppl. 3): 101 108 Printed in UK. All rights reserved Copyright Ó 2003 Blackwell Munksgaard Pediatric Transplantation ISSN 1398-2265 Hematopoietic stem and progenitor cell
More informationnow virtually as commonplace as getting a getting a flu shot. As the industry continues to grow
Over the past decade, the number of stem cell therapy providers has dramatically increased. From what was once a rare and medically advanced procedure, stem cell therapy is now virtually as commonplace
More informationNewborn Blood Banking, Inc. P.O. Box 270067 Tampa, Florida 33688 Phone (813) 948-2673
Please complete the following forms and send them back to us along with the registration fee to register. Once we receive your registration forms and payment, we will send you the collection kit. Mother
More informationLifeNet Health Presented by James Clagett, PhD., Chief Science Officer LifeNet Health - The Best Keep Secret in Regenerative Medicine
Presented by James Clagett, PhD., Chief Science Officer - The Best Keep Secret in Regenerative Medicine Corporate Headquarters Virginia Beach, VA Who is? helps save lives and restore health for thousands
More informationIn the Senate of the United States, AMENDMENT:
In the Senate of the United States, December, 01. Resolved, That the bill from the House of Representatives (H.R. 0) entitled An Act to reauthorize the Stem Cell Therapeutic and Research Act of 00, and
More informationSummary of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Status
of Advisory Council on Blood Stem Cell Transplantation: Recommendations and Shelley Grant Branch Chief, Blood Stem Cell Transplantation Program September 11, 2015 Overview December 20, 2005 - HRSA began
More informationASSEMBLY, No. 2591 STATE OF NEW JERSEY. 212th LEGISLATURE INTRODUCED FEBRUARY 23, 2006
ASSEMBLY, No. STATE OF NEW JERSEY th LEGISLATURE INTRODUCED FEBRUARY, 00 Sponsored by: Assemblywoman CHARLOTTE VANDERVALK District (Bergen) SYNOPSIS Requires hospitals to provide information to pregnant
More informationCHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION
CHAPTER 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION Chapter 1 BACKGROUND AND CORD BLOOD BANK (CBB) ORGANIZATION 1.1 OVERVIEW OF THE CORD BLOOD TRANSPLANTATION STUDY Bone marrow transplantation
More information1.2 - Overview of Regulation of Clinical Trials in Canada
1.2 - Overview of Regulation of Clinical Trials in Canada Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager, Clinical Group I Office
More informationPACT Web Seminar July 19, 2007
PACT Web Seminar July 19, 2007 Phyllis I. Warkentin, MD Professor, Pathology and Pediatrics University of NE Medical Center Medical Director Chairman, Accreditation Program Foundation for the Accreditation
More informationDepartment of Defense INSTRUCTION
Department of Defense INSTRUCTION NUMBER 6200.02 February 27, 2008 SUBJECT: Application of Food and Drug Administration (FDA) Rules to Department of Defense Force Health Protection Programs USD(P&R) References:
More informationPresented by Rosemarie Bell 24 April 2014
Global Good Manufacturing Practice A Comparability Study to Link Good Manufacturing Practice Standards for World Wide Compliance Within the Cellular Therapy Industry Presented by Rosemarie Bell 24 April
More informationCONSENT FORM. Cord Blood Banking for Transplantation
Cord Blood Program Northwest Tissue Center/Puget Sound Blood Center 921 Terry Avenue Seattle, WA 98104 (206) 292-1896 Swedish Medical Center 747 Broadway Seattle, WA 98122 (206) 386-6000 CONSENT FORM Cord
More information42 USC 274k. NB: This unofficial compilation of the U.S. Code is current as of Jan. 4, 2012 (see http://www.law.cornell.edu/uscode/uscprint.html).
TITLE 42 - THE PUBLIC HEALTH AND WELFARE CHAPTER 6A - PUBLIC HEALTH SERVICE SUBCHAPTER II - GENERAL POWERS AND DUTIES Part I - C.W. Bill Young Cell Transplantation Program 274k. National Program (a) Establishment
More informationGlobal Glossary of Terms and Definitions on Donation and Transplantation
Global Glossary of Terms and Definitions on Donation and Transplantation Geneva, November 2009 1 2 Global Glossary of terms and definitions on donation and transplantation The lack of a globally recognized
More informationCord blood banking: information for parents
Cord blood banking: information for parents Published August 2006 by the RCOG Contents Page number Key points 1 About this information 2 What is cord blood? 2 Why is cord blood useful? 3 How is cord blood
More informationGuidance for Industry and FDA Staff
Guidance for Industry and FDA Staff Investigational New Drug Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution
More informationPROVINCIAL/TERRITORIAL COUNCIL Of MINISTERS OF SECURITIES REGULATION (Council) ANNUAL PROGRESS REPORT January 2013 to December 2013
PROVINCIAL/TERRITORIAL COUNCIL Of MINISTERS OF SECURITIES REGULATION (Council) ANNUAL PROGRESS REPORT January 2013 to December 2013 BACKGROUND Since its formation in 2004, the Provincial-Territorial Council
More informationBlood Bank Application
New Renewal of Policy No. Blood Bank Application Some of the coverages you are applying for are Claims Made. If you have any questions concerning these coverages, please contact your insurance agent. Instructions:
More information4. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement on the Utility of Autologous or Family Cord Blood Unit Storage The WMDA Board adopted this policy on 25 th of May 2006. Policy updated _April 2011 The Cord Blood Working Group and
More informationNarrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood
[Track 2: What Is a Transplant?] Narrator: Transplants using stem cells from the blood, bone marrow or umbilical cord blood can be an effective treatment for people with blood cancers such as leukemia,
More informationTRANSATLANTIC TRADE AND INVESTMENT PARTNERSHIP
DISCLAIMER: The EU reserves the right to make subsequent modifications to this text and to complement its proposals at a later stage, by modifying, supplementing or withdrawing all, or any part, at any
More informationSTEM CELL THERAPEUTIC AND RESEARCH ACT OF 2005
STEM CELL THERAPEUTIC AND RESEARCH ACT OF 2005 VerDate 14-DEC-2004 06:53 Jan 05, 2006 Jkt 039139 PO 00000 Frm 00001 Fmt 6579 Sfmt 6579 E:\PUBLAW\PUBL129.109 APPS10 PsN: PUBL129 119 STAT. 2550 PUBLIC LAW
More informationInstructions for Completion of State of Maryland Tissue Bank Application
MarylandDepartmentofHealthandMentalHygiene OfficeofHealthCareQuality LaboratoryLicensingPrograms SpringGroveCenter BlandBryantBuilding 55WadeAvenue,Catonsville,MD21228 Phone:410.402.8025Fax:410.402.8213
More information5th Edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration. Summary of Changes
5th Edition NetCord-FACT International Standards for Cord Blood Collection, Banking, and Release for Administration Summary of Changes This document summarizes the changes made to the 5th edition of the
More informationU.S. Department of Health and Human Services. Are Distributed to Cord Blood Banks Participating In the National Cord Blood Inventory.
U.S. Department of Health and Human Services Interim DRAFT: Report DO to NOT Congress CIRCULATE on How Federal Funds Are Distributed to Cord Blood Banks Participating In the National Cord Blood Inventory
More informationJennifer Collins, RN Quality Liaison Ann & Robert H. Lurie Children's Hospital of Chicago
Jennifer Collins, RN Quality Liaison Ann & Robert H. Lurie Children's Hospital of Chicago General points of interest Facility Personnel Quality Management Policies & Procedures Donor Evaluation and Management
More informationNew Investigator Collaborations and Interactions: Regulatory
Your Health and Safety... Our priority Votre santé et votre Securité notre priorité New Investigator Collaborations and Interactions: Regulatory NCIC Clinical Trials Group New Investigator Clinical Trials
More informationCORD BLOOD TRANSPLANTATION STUDY EXPANDED ACCESS PROTOCOL APPENDIX A SAMPLE CONSENT FORM
APPENDIX A SAMPLE CONSENT FORM CORD BLOOD TRANSPLANTATION (COBLT) STUDY SAMPLE CONSENT FORM FOR THE EXPANDED ACCESS PROTOCOL You (your child) are being asked to take part in a clinical research study.
More informationTransmedcon 2014. Ahmedabad, Gujarat November 14-16, 2014
FACT Accreditation for Cord Blood Banks and Cellular Therapy Nadim Mahmud, MD, PhD Associate Professor of Medicine Division of Hematology/Oncology Director, Hospital Stem Cell Laboratory Blood & Marrow
More informationHouse Resolution No. 37
california legislature regular session House Resolution No. Introduced by Assembly Member Hill August, House Resolution No. Relative to umbilical cord blood banking. WHEREAS, Since the first umbilical
More informationLicensing Your Cord Blood
Licensing Your Cord Blood A Guide to Getting FDA Approval for Marketing your Public Bank s Lifesaving Product as a Prescription Drug 1.888.MEDIWARE Mediware.com Contents Introduction 1 Profits for Today,
More informationNorthwest Cardiology Associates 400 W. Northwest Hwy Barrington, IL 60010 847.382.4600 Fax 847.382.1771. HIPAA Notice of Privacy Practices ( Notice )
Northwest Cardiology Associates 400 W. Northwest Hwy Barrington, IL 60010 847.382.4600 Fax 847.382.1771 HIPAA Notice of Privacy Practices ( Notice ) THIS NOTICE DESCRIBES HOW INFORMATION ABOUT YOU MAY
More informationAssureImmune. Cord Blood: For Something That Precious, Bank with the Best. Important Facts for When You re Expecting. AssureImmune.
AssureImmune AssureImmune Cord Blood: For Something That Precious, Bank with the Best Important Facts for When You re Expecting Banking your baby s umbilical cord blood could be a potentially lifesaving
More informationSAVE A LIFE... BY GIVING LIFE!
SAVE A LIFE... BY GIVING LIFE! FOLLOW US ON: HÉMA-QUÉBEC PUBLIC CORD BLOOD BANK www.hema-quebec.qc.ca Scan this code with your smart phone to access the page Register to the Public Cord Blood Bank on the
More informationManagement Discussion and Analysis dated August 24, 2010, to accompany the financial statements for the year ended May 31, 2010
L I F E B A N K TM Corp. Saving Life s Most Precious Cells Technology Place BCIT Campus Suite 200 4475 Wayburne Drive Burnaby, British Columbia V5G 4X4 Tel: 604-738-2722 Fax:604-738-2726 info@lifebank.com
More informationDepartment of Veterans Affairs VHA DIRECTIVE 2012-018 Veterans Health Administration Washington, DC 20420 July 9, 2012
Department of Veterans Affairs VHA DIRECTIVE 2012-018 Veterans Health Administration Washington, DC 20420 SOLID ORGAN AND BONE MARROW TRANSPLANTATION 1. PURPOSE: This Veterans Health Administration (VHA)
More information2.2 Roles and Responsibilities in the Conduct and Assessment of Clinical Trials
L1 2.2 Roles and Responsibilities in the Conduct and Assessment of Clinical Trials Presentation to APEC Preliminary Workshop on Review of Drug Development in Clinical Trials Celia Lourenco, PhD, Manager,
More informationFlorida Medicaid. Transplant Services Coverage Policy
Florida Medicaid Agency for Health Care Administration June 2016 Table of Contents 1.0 Introduction... 1 1.1 Description... 1 1.2 Legal Authority... 1 1.3 Definitions... 1 2.0 Eligible Recipient... 2 2.1
More informationRegulation and Risk Management of Combination Products
Regulation and Risk Management of Combination Products Katherine Ulman Associate Scientist Global Regulatory Compliance Manager Dow Corning Healthcare Jim Curtis Senior Specialist, Healthcare Applications
More informationCentral Maine Healthcare
Central Maine Healthcare Administrative Policy No. HC-HI-5004(R2) HIPAA SUBJECT: Disclosures of Protected Health Information Policy Statement/Purpose: This policy sets forth the circumstances in which
More informationHow To Treat Leukaemia With Cord Blood Stem Cell
Cord blood for the treatment of acute lymphoblastic leukemia in young children By Caitlin McGreevy Kiara Paramjothy Pass with Merit RESEARCH PAPER BASED ON PATHOLOGY LECTURES AT MEDLINK 2011 1 Abstract:
More informationTransplant Coordinator
Have you signed your organ donor card? Hearts, kidneys, livers, and lungs can all be transplanted. When you die, one of your organs could help a critically ill patient live a longer life. What I do every
More informationCordBank Limited, which supplies processing and services with respect to cord blood. CordBank is referred to in this contract as CordBank or we ;
CORD BLOOD PROCESSING AND STORAGE CONTRACT This contract concerns the processing, storage and care of cord blood taken from your child s umbilical cord. This service will be supplied by CordBank on the
More informationHelping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.
Helping you find the one match.. Guide for Unrelated Stem Cell Transplant Patients OneMatch Stem Cell and Marrow Network BLOOD.CA WWW This guide is intended for patients in need of an unrelated volunteer
More informationCord Blood/Cord Tissue Storage Agreement
Cord Blood/Cord Tissue Storage Agreement The following definitions are used in this Agreement: child sample you/your SCI/us/we your child from whose umbilical cord the Sample is taken; the sample of cord
More informationCoverage is subject to a Deductible
Frank Cowan Company Limited 75 Main Street North, Princeton, ON N0J 1V0 Phone: 519-458-4331 Fax: 519-458-4366 Toll Free: 1-800-265-4000 www.frankcowan.com CYBER RISK INSURANCE DETAILED APPLICATION Notes:
More informationUNDERSTANDING THE EC DIRECTIVE 98/79/EC ON IN VITRO DIAGNOSTIC MEDICAL DEVICES
UNDERSTANDING THE EC DIRECTIVE 98/79/EC ON IN VITRO DIAGNOSTIC MEDICAL DEVICES A WHITE PAPER ON THE REQUIREMENTS, REGULATIONS AND OPPORTUNITIES CONTAINED IN EC DIRECTIVE 98/79/EC AND A BRIEF COMPARISON
More informationREGISTRATION REQUIREMENT
REGISTRATION REQUIREMENT An in-state athlete agent must register with the Commission prior to directly or indirectly serving or offering to serve as an athlete agent in the Commonwealth. An out-of-state
More informationStem cells will change medicine as we know it. Are you ready? STEM CELL BANKING
Stem cells will change medicine as we know it. Are you ready? STEM CELL BANKING Stem cell banking with Store-A-Tooth is a unique investment in the health of your family. WHY BANK STEM CELLS? YOU PLAN FOR
More informationIF YOU HAVE ANY QUESTIONS ABOUT THIS NOTICE OR IF YOU NEED MORE INFORMATION, PLEASE CONTACT OUR PRIVACY OFFICER:
NOTICE OF PRIVACY PRACTICES COMPLETE EYE CARE THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED OR DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationNotice of Privacy Practices
Notice of Privacy Practices THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY. About this notice
More informationTHE PROMISE OF STEM CELL RESEARCH
THE PROMISE OF STEM CELL RESEARCH MALIGNANT OSTEOPETROSIS AUTOSOMAL RECESSIVE DENSE SCLEROTIC SKELETON HEMATOLOGIC ABNORMALITIES NEUROLOGIC ABNOMALITIES DEATH IN INFANCY OR EARLY CHILDHOOD SUCCESS RATE
More informationHypnotherapist Registration Application Packet
Hypnotherapist Registration Application Packet Contents: 1. 670-088...Contents List/SSN Information/Mailing Information...1 page 2. 670-053...Application Instruction Checklist... 2 pages 3. 670-052...Hypnotherapy
More information15 Stem Cell Research
15 Stem Cell Research t a l k it o v e r 1 c l a s s se s s i o n Overview Students read about current scientific research on and the social controversy over embryonic stem cells. On a KWL literacy strategy
More informationDate of birth Gender NHS number (if known) Town/Country of birth. Home Telephone no. Work Telephone no.
ADULT - FEB 15 Office use only Staff initials Date ID seen Welcome to Wokingham Medical Centre Thank you for completing this registration form. When registering in person at the surgery please supply two
More informationHIPAA Privacy Notice
HIPAA Privacy Notice This notice describes how medical information about you may be used and disclosed and how you can get access to this information. Please review it carefully. This notice describes
More informationHow To Know If A Mobile App Is A Medical Device
The Regulation of Medical Device Apps Prepared for West of England Academic Health Science Network and University of Bristol June 2014 June 2014 1 Table of Contents 1 Purpose...3 2 Scope...3 3 The Regulation
More informationH. R. 2107 IN THE HOUSE OF REPRESENTATIVES
I 1TH CONGRESS 1ST SESSION H. R. 2107 To direct the Secretary of Health and Human Services to conduct a public education campaign on umbilical cord blood stem cells, and for other purposes. IN THE HOUSE
More informationthe future in your hands imagine
the future in your hands imagine The promise of hope Carrie and Wilf s story... Quinn weighed in at a healthy 4397g at birth. His parents, Carrie and Wilf, had decided to store the umbilical cord blood
More informationNOTICE OF PRIVACY PRACTICES ILLINOIS EYE CENTER
NOTICE OF PRIVACY PRACTICES ILLINOIS EYE CENTER THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED OR DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE REVIEW IT CAREFULLY.
More informationPl"OtocolDirector: Iris Schrijver _ IRB Approval Date: _June 20 2006 IRE Expiration Date: June 19, 2007 _ STANFORD SAMPLE CONSENT FORM
Protocol Title: Molecular genetic basis of sensorineural hearing Pl"OtocolDirector: Iris Schrijver IRB Approval Date: June 20 2006 IRE Expiration Date: June 19, 2007 STANFORD SAMPLE CONSENT FORM Please
More informationDESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004
DESCRIPTION OF THE MEDICINES FOR HUMAN USE (CLINICAL TRIALS) REGULATIONS 2004 Page 1 of 17 TABLE OF CONTENTS INTRODUCTION 4 EXECUTIVE SUMMARY 4 PUBLIC HEALTH BENEFITS 5 Good clinical practice 5 Good manufacturing
More informationAlexander Smolyaninov,
«German-Russian Forum Biotechnology and Life Sciences» September, 2006 St. Petersburg Center of Cell and Gene Therapy «CRYOCENTER SAINT PETERSBURG» Stem Cell Bank «POKROVSKI» Alexander Smolyaninov, M.D.,Ph.D.,
More informationRoche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
More informationOFFICE OF THE ARIZONA ATTORNEY GENERAL Mark Brnovich. STATE OF ARIZONA DURABLE HEALTH CARE POWER OF ATTORNEY Instructions and Form
OFFICE OF THE ARIZONA ATTORNEY GENERAL Mark Brnovich STATE OF ARIZONA DURABLE HEALTH CARE POWER OF ATTORNEY Instructions and Form GENERAL INSTRUCTIONS: Use this Durable Health Care Power of Attorney form
More informationStem Cell Quick Guide: Stem Cell Basics
Stem Cell Quick Guide: Stem Cell Basics What is a Stem Cell? Stem cells are the starting point from which the rest of the body grows. The adult human body is made up of hundreds of millions of different
More informationUnique Device Identification System: Small Entity Compliance Guide Guidance for Industry and Food and Drug Administration Staff
Unique Device Identification System: Small Entity Compliance Guide Guidance for Industry and Food and Drug Administration Staff Document issued on August 13, 2014 On November 5, 2014 this document was
More informationA Guide To Cord Blood Banking
A Guide To Cord Blood Banking For Families with Genetic Conditions Cord Blood Banking This leaflet is aimed at families who might be considering storing cord blood for the treatment of a child or other
More information5. All cord blood banks should be subject to the same standards, regulations and accreditation requirements.
WMDA Policy Statement for the Utility of Autologous or Family Cord Blood Unit Storage (This policy statement has been approved and adopted by the WMDA board on the 25 th of May 2006) The Cord Blood Registries
More informationRisk Management Plan (RMP) on Biologicals and NCE
Transformation towards a New Regulatory Paradigm Risk Management Plan (RMP) on Biologicals and NCE Junko SATO International Coordination Officer PMDA, Japan 1 2 Pharmaceuticals and Medical Devices Agency
More informationSTEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA
STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the
More informationMarihuana for Medical Purposes Regulations. October 16, 2014
Marihuana for Medical Purposes Regulations October 16, 2014 Overview Provide an overview of the evolution of marihuana for medical purposes regulations in Canada Status of the old program/ Allard Injunction
More informationSTEM CELL FELLOWSHIP
Module I: The Basic Principles of Stem Cells 1. Basics of Stem Cells a. Understanding the development of embryonic stem cells i. Embryonic stem cells ii. Embryonic germ cells iii. Differentiated stem cell
More informationA A E S C. Albuquerque Ambulatory Eye Surgery Center NOTICE OF PRIVACY PRACTICES
A A E S C Albuquerque Ambulatory Eye Surgery Center NOTICE OF PRIVACY PRACTICES THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION.
More informationDrug Supply Chain Security Act (Title II of the Drug Quality and Security Act) Overview and Implementation
Drug Supply Chain Security Act (Title II of the Drug Quality and Security Act) Overview and Implementation Connie Jung, RPh, PhD U.S. Food and Drug Administration NACDS Total Store Expo August 24, 2014
More informationREGISTRATION PACKET INSTRUCTIONS
1 REGISTRATION PACKET INSTRUCTIONS Registration Packet Instructions Check List Thank you for requesting the Alpha Cord Registration Packet. You will find all of the materials you need to complete your
More informationElectronic Health Record Sharing System Bill. Contents. Part 1. Preliminary. 1. Short title and commencement... C1203. 2. Interpretation...
C1193 Electronic Health Record Sharing System Bill Contents Clause Page Part 1 Preliminary 1. Short title and commencement... C1203 2. Interpretation... C1203 3. Substitute decision maker... C1213 4. Ordinance
More informationWe ask that you allow our office 24-48 hours to respond to telephone messages and callbacks.
NOTICE OF PRIVACY PRACTICE Associated Physicians Group This notice describes how your medical information may be disclosed and how you can get access to this information. Please review these policies carefully.
More informationTable of Contents. FACT Quality Handbook, Second Edition. Table of Contents
Table of Contents INTRODUCTION... i ACKNOWLEDGEMENTS... ii 1. Quality Management Program Overview... 1 Diagram of Quality Program Elements... 9 Sample Quality Management Performance Summary: Colorado Blood
More informationCord blood donation is a painless and free gesture, helping others and saving lives.
Cord blood donation is a painless and free gesture, helping others and saving lives. Cord blood, a bond for life. GRANDE CAUSE NATIONALE 2009 Donation for scientific research If your donation does not
More information